X4 insider buying disclosures show Executive Chairman Adam Craig purchased 4,600 shares of X4 Pharmaceuticals on October 16, 2026, bringing his reported holdings to 333,251 shares. The transaction added modestly to an existing stake rather than establishing a new position.
Key Takeaways
- Craig’s purchase increased his reported stake by approximately 1.4%.
- The SEC filing record was submitted on October 19, covering the October 16 transaction.
- Craig’s reported purchases exceeded his sales over the preceding year, while companywide sales outnumbered purchases.
Table of Contents
- X4 insider buying increases Craig’s existing stake
- Annual trading history provides a mixed backdrop
- Conclusion
X4 insider buying increases Craig’s existing stake
The purchase raised Craig’s holdings from an implied 328,651 shares to 333,251 shares. That makes the addition small relative to his existing position, a useful distinction when assessing the size of an insider transaction.
The SEC’s October 19 Form 4 filing record identifies Adam R. Craig as the reporting person and X4 Pharmaceuticals as the issuer, with an October 16, 2026 reporting period. The filing-detail page establishes the disclosure’s identity and timing but does not itself display the purchase quantity or resulting holding.
X4 shares were reported trading at $2.58 on the transaction date. That market-price reference should not be treated as a verified execution price for Craig’s purchase.
| Item | Details |
|---|---|
| Craig’s purchases over the preceding year | 90,806 shares |
| Craig’s sales over the preceding year | 47,436 shares |
| Companywide insider purchases | 2 transactions over the preceding year |
| Companywide insider sales | 5 transactions over the preceding year |
Annual trading history provides a mixed backdrop
Craig’s reported activity over the preceding year included both purchases and sales. His purchases exceeded his sales by 43,370 shares, based on the supplied totals, so the latest transaction sits within a broader history of position changes.
Across X4 insiders, sale transactions outnumbered purchase transactions during the same period. Those counts measure transactions, not the number of individual insiders or the dollar value traded, and therefore do not establish the overall financial balance of buying and selling.
The disclosure documents an ownership change, not Craig’s reason for buying or a forecast for X4’s shares. The transaction alone does not establish a change in the company’s operating prospects.
Conclusion
Craig’s latest purchase modestly expanded his X4 stake. Subsequent ownership disclosures would show whether he continues adding shares; the October transaction alone does not establish a continuing buying pattern.
Read More News
Disclaimer
This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.
